1ISG-007 Economic savings from weight-based dosing of pembrolizumab: what is the impact in a tertiary hospital?
| Autor: | E Mateos Egido, A Dominguez Fariña, ÁMAttenya María, D Dorta Vera, I Ruiz Santos, M Lombardero Pin, C Otero Villalustre, ME Luján López, D Fernández Vera |
|---|---|
| Rok vydání: | 2022 |
| Zdroj: | Section 1: Introductory statements and governance. |
| DOI: | 10.1136/ejhpharm-2022-eahp.5 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|